2019-05-23 |
1 |
Complaint |
and lawfully issued United States Patent No. 9,200,088 (“the ’088 patent”),
entitled “Sulfoalkyl Ether … COUNT I FOR INFRINGEMENT OF U.S. PATENT NO. 9,200,088
26. CyDex realleges and incorporates…and interest in the ’088
patent and the ’582 patent (collectively, “the patents-in-suit”).
… 1. This is an action for patent infringement under the patent laws of the United
States arising…. This is an action for patent infringement arising under the Patent Laws of the
United States, |
External link to document |
2020-11-01 |
122 |
Opinion - Memorandum Opinion |
infringement of an additional patent, U.S. Patent No. 8,410,077 (the 077
patent”) (D.I. 41 Ex. C). (See generally…of U.S. Patent Nos. 9,200,088 (the “088 patent”) (D.I. 1 Ex. A); and 9,493,5 82
(the “582 patent”) (D.I…. “It is a bedrock principle of patent law that the
claims of a patent define the invention to which the…reading the entire patent.” fd. at 1321
(internal quotation marks omitted). The patent “specification is….” (582 patent at 6:19-34) The Court’s construction
| This term appears in the 088 patent at claims |
External link to document |
2021-06-10 |
149 |
~Util - Terminate Civil Case AND Order |
States Patent Nos. 8,410,077, 9,200,088, and 9,493,582 (collectively, the
"CyDex Patents")…States or with
respect to any patent other than the CyDex Patents.
10. For purposes of…JUDGMENT AND DISMISSAL ORDER
This action for patent infringement (the "Litigation") has been… § 355(j)(2)(A)(vii)(IV) directed to the CyDex Patents and seeking approval to market
a generic melphalan…injection prior to the expiration of the CyDex Patents.
CyDex and Alembic have agreed to enter |
External link to document |
2020-01-29 |
39 |
Patent/Trademark Report to Commissioner of Patents |
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,410,077 B2 (First Amended Complaint…2019
10 June 2021
1:19-cv-00956
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2019-05-23 |
4 |
Patent/Trademark Report to Commissioner of Patents |
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,200,088 B2 ;9,493,582 B2. (…2019
10 June 2021
1:19-cv-00956
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2020-02-06 |
41 |
Complaint - Amended |
COUNT III FOR INFRINGEMENT OF U.S. PATENT NO. 8,410,077
45. CyDex realleges and …interest in the ’088
patent, the ’077 patent, and the ’582 patent (collectively, “the patents-in-suit”).
… 1. This is an action for patent infringement under the patent laws of the United
States arising…. This is an action for patent infringement arising under the Patent Laws of the
United States, … THE PATENTS-IN-SUIT
18. On December 1, 2015, the United States Patent and Trademark |
External link to document |